157 related articles for article (PubMed ID: 37907261)
21. A family with Sertoli-Leydig cell tumour, multinodular goiter, and
Haley M; Bindal P; McAuliffe A; Vredenburgh J
Curr Oncol; 2019 Jun; 26(3):183-185. PubMed ID: 31285663
[TBL] [Abstract][Full Text] [Related]
22. Gynecologic Manifestations of the DICER1 Syndrome.
Stewart CJ; Charles A; Foulkes WD
Surg Pathol Clin; 2016 Jun; 9(2):227-41. PubMed ID: 27241106
[TBL] [Abstract][Full Text] [Related]
23. DICER1 hotspot mutations in ovarian Sertoli-Leydig cell tumors: a potential association with androgenic effects.
Kato N; Kusumi T; Kamataki A; Tsunoda R; Fukase M; Kurose A
Hum Pathol; 2017 Jan; 59():41-47. PubMed ID: 27664536
[TBL] [Abstract][Full Text] [Related]
24. Ovarian sex cord-stromal tumors in patients with probable or confirmed germline DICER1 mutations.
Oost EE; Charles A; Choong CS; Leung YC; Salfinger S; Sonnendecker H; Tan J; Townshend S; Witkowski L; Foulkes WD; Stewart CJ
Int J Gynecol Pathol; 2015 May; 34(3):266-74. PubMed ID: 25844550
[TBL] [Abstract][Full Text] [Related]
25. Testicular Sertoli cell tumour and potentially testicular Leydig cell tumour are features of
Golmard L; Vasta LM; Duflos V; Corsini C; Dubois d'Enghien C; McMaster ML; Harney LA; Carr AG; Ling A; Dijoud F; Gauthier A; Miettinen M; Cost NG; Gauthier-Villars M; Orbach D; Irtan S; Haouy S; Schultz KA; Stoppa-Lyonnet D; Coupier I; Stewart DR; Sirvent N
J Med Genet; 2022 Apr; 59(4):346-350. PubMed ID: 33782093
[No Abstract] [Full Text] [Related]
26. Detection of the DICER1 hotspot mutation alongside immunohistochemical analysis may provide a better diagnostic measure for ovarian Sertoli-Leydig cell tumors.
Zhang X; Shen D; Wang Y
Pathol Res Pract; 2018 Sep; 214(9):1370-1375. PubMed ID: 30072170
[TBL] [Abstract][Full Text] [Related]
27. Clinical Characteristics and Mutation Analyses of Ovarian Sertoli-Leydig Cell Tumors.
Yuan Z; Huo X; Jiang D; Yu M; Cao D; Wu H; Shen K; Yang J; Zhang Y; Zhou H; Wang Y
Oncologist; 2020 Sep; 25(9):e1396-e1405. PubMed ID: 32557933
[TBL] [Abstract][Full Text] [Related]
28. Novel pathogenic variant of
Rivera-Hernández A; Madrigal-González M; Mejía-Carmona L; Martínez-López I; Pérez-Hernández MG; Bernal-Manjarrez J; Luna-Vidal S; Reta-Guerrero S; Rodríguez-Florido MA; Balcázar-Hernández L
J Pediatr Endocrinol Metab; 2023 Aug; 36(8):782-785. PubMed ID: 37307239
[TBL] [Abstract][Full Text] [Related]
29. [Ovarian Sertoli-Leydig cell tumors: DICER1 hotspot mutations and associated clinicopathological features].
Xiao YX; Zhu XL; Bi R; Tu XY; Cheng YF; Chang B; Yu L; Huang D; Lu YM; Shan L; Yang WT
Zhonghua Bing Li Xue Za Zhi; 2020 May; 49(5):441-447. PubMed ID: 32392927
[No Abstract] [Full Text] [Related]
30. The co-occurrence of an ovarian Sertoli-Leydig cell tumor with a thyroid carcinoma is highly suggestive of a DICER1 syndrome.
Durieux E; Descotes F; Mauduit C; Decaussin M; Guyetant S; Devouassoux-Shisheboran M
Virchows Arch; 2016 May; 468(5):631-6. PubMed ID: 26983701
[TBL] [Abstract][Full Text] [Related]
31. Ovarian Sertoli-Leydig cell tumours: How typical is their typical presentation?
Melero Cortés LM; Martínez Maestre MÁ; Vieites Pérez-Quintela MB; Gambadauro P
J Obstet Gynaecol; 2017 Jul; 37(5):655-659. PubMed ID: 28485183
[TBL] [Abstract][Full Text] [Related]
32. Distinct somatic DICER1 hotspot mutations in three metachronous ovarian Sertoli-Leydig cell tumors in a patient with DICER1 syndrome.
Garcia A; Desrosiers L; Scollon S; Gruner S; Reuther J; Gandhi I; Patil N; Fuller MY; Dai H; Muzny D; Gibbs RA; Bercaw-Pratt JL; Rao SL; Rainusso N; Fisher KE; Lin FY; Plon SE; Parsons DW; Roy A
Cancer Genet; 2022 Apr; 262-263():53-56. PubMed ID: 35026696
[No Abstract] [Full Text] [Related]
33. Bilateral Ovarian Sertoli-Leydig Cell Tumors Harboring
Hughes CE; Liang J; Paulson V; Wang H
Fetal Pediatr Pathol; 2023 Jun; 42(3):472-478. PubMed ID: 36121434
[No Abstract] [Full Text] [Related]
34. The role of FOXL2, SOX9, and β-catenin expression and DICER1 mutation in differentiating sex cord tumor with annular tubules from other sex cord tumors of the ovary.
Onder S; Hurdogan O; Bayram A; Yilmaz I; Sozen H; Yavuz E
Virchows Arch; 2021 Aug; 479(2):317-324. PubMed ID: 33566167
[TBL] [Abstract][Full Text] [Related]
35. Sertoli-Leydig cell tumor of the ovary: analysis of a single institution database.
Bhat RA; Lim YK; Chia YN; Yam KL
J Obstet Gynaecol Res; 2013 Jan; 39(1):305-10. PubMed ID: 22691037
[TBL] [Abstract][Full Text] [Related]
36. Somatic tumour testing establishes that bilateral DICER1-associated ovarian Sertoli-Leydig cell tumours represent independent primary neoplasms.
McCluggage WG; Chong AL; de Kock L; Foulkes WD
Histopathology; 2020 Aug; 77(2):223-230. PubMed ID: 32333409
[TBL] [Abstract][Full Text] [Related]
37. Ovarian sex cord-stromal tumors--a clinicopathological study of 72 cases from the Kiel Pediatric Tumor Registry.
Schneider DT; Jänig U; Calaminus G; Göbel U; Harms D
Virchows Arch; 2003 Oct; 443(4):549-60. PubMed ID: 12910419
[TBL] [Abstract][Full Text] [Related]
38. A Genome-First Approach to Characterize DICER1 Pathogenic Variant Prevalence, Penetrance, and Phenotype.
Mirshahi UL; Kim J; Best AF; Chen ZE; Hu Y; Haley JS; Golden A; Stahl R; Manickam K; Carr AG; Harney LA; Field A; Hatton J; Schultz KAP; Bauer AJ; Hill DA; Rosenberg PS; Murray MF; Carey DJ; Stewart DR
JAMA Netw Open; 2021 Feb; 4(2):e210112. PubMed ID: 33630087
[TBL] [Abstract][Full Text] [Related]
39. Genetics and genomics of ovarian sex cord-stromal tumors.
Fuller PJ; Leung D; Chu S
Clin Genet; 2017 Feb; 91(2):285-291. PubMed ID: 27813081
[TBL] [Abstract][Full Text] [Related]
40. [Application of molecular analysis in differential diagnosis of ovarian adult granulosa cell tumors].
Zheng XZ; Ma JH; Chen TB; Xu F; Zou ZY; Zhang LH; Jin YL; Zhan Y
Zhonghua Bing Li Xue Za Zhi; 2020 Aug; 49(8):794-799. PubMed ID: 32746545
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
